US Military Action in Venezuela Impacts 10 Indian Listed Companies Across Sectors
US military action in Venezuela affects multiple Indian listed companies across energy, pharmaceutical, and industrial sectors. Key players include ONGC and Reliance Industries in oil, Sun Pharma and Glenmark in pharmaceuticals, and Jindal Steel in metals, highlighting geopolitical risks in cross-border operations.

*this image is generated using AI for illustrative purposes only.
The United States' military action against Venezuela has created significant implications for Indian listed companies with exposure to the Latin American nation through energy assets, crude trade, engineering services, and pharmaceutical operations. The strikes, which targeted Venezuela's air defence systems and resulted in the capture of President Nicolas Maduro, have heightened investor uncertainty across multiple sectors.
Energy Sector Companies Face Direct Impact
India's primary exposure to Venezuela centers on the oil and gas sector, where several major companies maintain significant operations. ONGC holds equity stakes in two oil projects in Venezuela, providing direct upstream presence in the country. Reliance Industries (RIL) has historically been a major importer of Venezuelan crude oil.
| Energy Company Exposure: | Details |
|---|---|
| ONGC: | Equity stakes in two oil projects |
| Reliance Industries: | Major Venezuelan crude importer |
| Indian Oil Corporation: | Consortium partner in Carabobo project |
| Oil India: | Minority partner in joint venture |
| MRPL: | Historical Venezuelan oil sourcing |
According to international brokerage Jefferies, both ONGC and Reliance Industries are positioned as key beneficiaries of a prospective US-led restructuring of Venezuela's oil industry. Analysts suggest these companies could gain through improved supplies, cash flows, and valuations if sanctions are eased. Reliance Industries hit a record high on Monday, while ONGC ended approximately 2.00% lower after paring earlier gains.
Pharmaceutical and Industrial Companies Show Varied Exposure
Beyond energy, several Indian pharmaceutical companies maintain operations in Venezuela through subsidiaries and export arrangements. Sun Pharma operates through a registered Venezuelan subsidiary, while Glenmark Pharma maintains locally registered operations in the country.
| Non-Energy Sector Exposure: | Company Details |
|---|---|
| Sun Pharma: | Registered Venezuelan subsidiary |
| Glenmark Pharma: | Local subsidiary operations |
| Cipla: | Historical medicine exports |
| Dr Reddy's: | Divested subsidiary stake in 2024 |
| Engineers India: | Overseas office in Caracas |
| Jindal Steel: | Operates largest iron ore complex |
Cipla has historically exported essential medicines to Venezuela, indicating ongoing trade exposure to potential disruptions. Dr Reddy's Laboratories previously maintained a subsidiary but divested its entire stake in 2024, significantly reducing current exposure.
Market Response Reflects Geopolitical Risk Assessment
The military operation, involving the disabling of Venezuela's air defence systems and a swift raid in Caracas, has drawn mixed international reactions. The United Nations and legal experts have raised questions regarding the action's legality, adding to market uncertainty.
| Market Impact Analysis: | Current Status |
|---|---|
| Gold Price: | Surged past $4,400 per ounce |
| Asian Equities: | Trading strongly higher |
| Oil Markets: | Remained relatively stable |
| Precious Metals: | Strong safe-haven demand |
For Indian companies with Venezuelan exposure, the developments highlight risks associated with geopolitical flashpoints and cross-border operations, particularly in regions marked by political and economic instability. Any disruption to Venezuela's oil production, exports, or logistics could affect energy companies' supply chains and operational cash flows.
Long-Term Implications for Cross-Border Operations
The situation underscores the complex relationship between geopolitical developments and corporate exposure in emerging markets. Companies with Venezuelan operations must navigate potential supply disruptions, regulatory changes, and operational challenges stemming from the ongoing crisis.
Engineers India's Caracas office and Jindal Steel's iron ore operations represent significant on-ground presence that could face immediate operational impacts. The pharmaceutical companies' export relationships may experience disruptions depending on how the situation evolves and what sanctions or trade restrictions emerge.



























